Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate.

Item

http://www.wikidata.org/entity/Q43641073

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Leflunomide addition in patien ...... tis resistant to methotrexate.

@en

Leflunomide addition in patien ...... tis resistant to methotrexate.

@nl

type

Item

label

Leflunomide addition in patien ...... tis resistant to methotrexate.

@en

Leflunomide addition in patien ...... tis resistant to methotrexate.

@nl

prefLabel

Leflunomide addition in patien ...... tis resistant to methotrexate.

@en

Leflunomide addition in patien ...... tis resistant to methotrexate.

@nl

P1476

Leflunomide addition in patien ...... tis resistant to methotrexate.

@en

P2093

Athanasios D Anastasilakis

http://www.w3.org/2001/XMLSchema#string

Fares E Sayegh

http://www.w3.org/2001/XMLSchema#string

George A Kapetanos

http://www.w3.org/2001/XMLSchema#string

Grigorios T Sakellariou

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis.

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.

Treatment recommendations for psoriatic arthritis.

Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.

Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies.

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.

Tolerability of methotrexate and leflunomide combination therapy for inflammatory arthritis in routine clinical practice: results of a four-centre study.

P2888

s00296-012-2534-x

P304

2917-2920

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00296-012-2534-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038400490

http://www.w3.org/2001/XMLSchema#string

P698

23124729

http://www.w3.org/2001/XMLSchema#string